Published On: Fri, Mar 20th, 2020

Daily Crunch: Facebook and Twitter quarrel coronavirus misinformation

The large amicable networks take stairs to safeguard that they’re providing accurate information for open health, Charter refuses to concede employees to work from home and Microsoft Teams sees a large spike in popularity. Here’s your Daily Crunch for Mar 19, 2020.

1. Facebook will put a new coronavirus info core on tip of a News Feed

In an bid to disseminate infallible health information on COVID-19, Facebook will hurl out a possess coronavirus information core — a executive heart where a association will collect information from sources like a CDC and WHO.

Meanwhile, Twitter updated a reserve process to demarcate tweets that “could place people during a aloft risk of transmitting COVID-19.” The new process bans tweets denying consultant superintendence on a virus, enlivening “fake or ineffectual treatments, preventions and evidence techniques,” as good as tweets that trick users by sanctimonious to be from health authorities or experts.

2. Charter staff told to news to offices notwithstanding certain coronavirus tests

The phone and internet giant, that owns a Spectrum brand, has doubled down in a past week on a process of disallowing a 15,000 office-based employees to work from home, call one operative to quit over fears he would agreement a illness. Dozens of other Charter employees have contacted TechCrunch in a past few days with concerns about their stream operative conditions.

3. Microsoft Teams jets to 44M DAUs, announces new facilities as remote work booms

Microsoft’s Team product is a Slack aspirant and a expected patron of a COVID-19 remote work boom. The new figure represents a outrageous benefit on a series Microsoft common in Nov 2019, when a product had 20 million DAUs.

4. Home diagnostics startup Everlywell is rising an at-home coronavirus exam representation kit

Everlywell’s exam pack includes swab-based collection equipment, as good as shipping materials that safeguard protected ride of a person’s sample, that is afterwards tested by labs approved for COVID-19 contrast underneath a FDA Emergency Use Authorization.

5. The 20 best startups from Y Combinator’s W20 Demo Day

With universe events overtaking a tech industry’s welfare for coffee meetings and in-person events, Y Combinator skipped a famous two-day live Demo Day and went for a radical experiment: no demos during all, though instead a prolonged list of a scarcely 200 startups in a Winter 2020 batch, with links to their sites and one-page slides. (Extra Crunch membership required.)

6. Ada raises $44M Series B to urge a chatbot patron use platform

“Although AI gets thrown around a lot in a enterprise, we are focused on companies charity solutions that are pushing genuine business value, and Ada is doing accurately that,” pronounced Accel partner Ben Fletcher. “Ada is violation by a swarming marketplace of chatbots to conclude a new difficulty of programmed patron knowledge that can conduct distant larger patron exploration volumes while delivering some of a strongest patron compensation scores we’ve seen.”

7. COVID-19 updates

While a Daily Crunch has been packaged with headlines about a tellurian pandemic, there’s still copiousness of news that I’m withdrawal out. So if we wish to stay entirely up-to-date, revisit the heart for COVID-19 coverage.

The Daily Crunch is TechCrunch’s roundup of the biggest and many critical stories. If you’d like to get this delivered to your inbox each day during around 9am Pacific, we can allow here.

About the Author